HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Milano, A. D. Articles by Gallucci, V. Search for Related Content PubMed PubMed Citation Articles by Milano, A. D. Articles by Gallucci, V.

The Annals of Thoracic Surgery, Vol 46, 216-222, Copyright © 1988 by The Society of Thoracic Surgeons

ARTICLES

Performance of the Hancock porcine bioprosthesis following aortic valve replacement: considerations based on a 15-year experience

AD Milano, U Bortolotti, A Mazzucco, F Guerra, G Stellin, E Talenti, G Thiene and V Gallucci
Department of Cardiovascular Surgery, University of Padova Medical School, Italy.

All patients undergoing isolated aortic valve replacement with a standard Hancock porcine bioprosthesis (PB), from 1970 to 1983, were reviewed. There were 196 patients, 162 male and 34 female patients, with a mean age of 48 +/- 12 years. Operative survivors were followed up from 3 to 15.6 years (mean follow-up, 6.6 +/- 1.5 years), with a cumulative follow-up of 1,140 patient-years, being 100% complete. Actuarial survival was 51 +/- 15% at 14 years. Eight patients sustained systemic embolic episodes (0.7 +/- 0.2%/patient-year); actuarial freedom from emboli is 89.4 +/- 4.3% at 14 years. Reoperation was performed in 53 patients: in 6 because of endocarditis (0.5 +/- 0.2%/patient-year), in 7 because of perivalvular leak (0.6 +/- 0.2%/patient-year), and in 40 because of PB primary tissue failure (3.5 +/- 0.5%/patient-year). Actuarial freedom from PB-related deaths, PB failure, and overall PB-related complications at 14 years was 66.3 +/- 19, 34.3 +/- 11, and 30 +/- 10%, respectively. This long-term experience shows that the performance of the Hancock PB appears satisfactory up to 8 years, while it progressively deteriorates beyond 10 years because of the impact of primary tissue failure on valve durability, justifying the restriction of its use in the aortic position in selected patients.

This article has been cited by other articles:

				N. D. Desai and G. T. Christakis Stented Mechanical/Bioprosthetic Aortic Valve Replacement Card. Surg. Adult, January 1, 2003; 2(2003): 825 - 856. [Full Text]

				B. Yamak, B. Mavitas, A. Saritas, S F. Katircioglu, A T. Ulus, L. Birincioglu, Y H. Karagoz, E. Sener, O. Tasdemir, and K. Bayazit Ten-Year Results With Liotta Porcine Bioprostheses in the Mitral Position Asian Cardiovasc Thorac Ann, December 1, 1998; 6(4): 260 - 264. [Abstract] [Full Text] [PDF]

				G. B. Luciani, P. Bertolini, and A. Mazzucco EARLY FAILURE OF FREEHAND AORTIC STENTLESS XENOGRAFT VALVES J. Thorac. Cardiovasc. Surg., June 1, 1997; 113(6): 1109 - 1110. [Full Text]

				J. I. Fann, D. C. Miller, KathleenA. Moore, R. S. Mitchell, P. E. Oyer, E. B. Stinson, R. C. Robbins, B. A. Reitz, and N. E. Shumway Twenty-Year Clinical Experience With Porcine Bioprostheses Ann. Thorac. Surg., November 1, 1996; 62(5): 1301 - 1311. [Abstract] [Full Text]

				U. Bortolotti, A. Milano, G. Thiene, and A. Mazzucco Original expectations of the Hancock valve and 20 years of clinical reality Eur. J. Cardiothorac. Surg., January 1, 1992; 6(suppl_1): S75 - S78. [Abstract] [PDF]